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A total of 279 patients with squamous cell carcinoma (Scq, 
169 with basal cell carcinoma (BCq, and 91 with malignant 
melanoma (MM) were treated at Saitama Medical School and 
the National Cancer Center (NCq. This statistical study 
was done to compare an early period (1962 -1972) and recent 
period (1973 -1985). The yearly onset of melanoma patients 
increased 3.4 times and that of basal cell carcinoma increased 
1.8 times, while the percent of squamous cell carcinoma 
patients decreased slightly. The male/female ratio was 1.6 
versus 1.1 for basal cell carcinoma, 2.0 versus 1.7 for squa­
mous cell carcinoma, and 1.7 versus 1.2 for malignant mela­
noma in the early versus late periods. 
The age distribution of malignant melanoma patients 
showed a sudden increase after 20, which peaked in the fifties 
N ationwide surveys of malignant skin tumors in Japan are rare; only three reports are available. In 1962 Segi and Takano [1] reported on 191 cases among dermatology patients in 120 hospitals [1]. The next report which surveyed 1137 cases of ma­
lignant skin tumors in 41 university hospitals between 1956 and 
1960, was published by Miyagi in 1963 [2]. The most recent study 
by Tada and Miki [3] reported on 2027 cases of malignant skin 
tumors in 44 university hospitals between 1971 and 1975. Tada and 
Miki compared the recent status and chronological change of the 
incidence of malignant skin tumors with that reported earlier by 
Miyagi [2]. They also studied the geographic correlations with the 
incidence of malignant melanoma and non-melanoma skin cancer. 
They concluded that the incidence of non-melanoma skin cancer 
was elevated to a statistically significant degree on sun-exposed skin. 
No such correlation was seen in the case of malignant melanoma. 
The present survey was done between 1967 and 1985 on 1396 
patients with malignant skin tumors treated at Saitama Medical 
School and National Cancer Center Hospital (NCe). 
Reprint requests to: Shigeo Ikeda, M.D., Department of Dermatology, 
Saitama Medical School, 38 Morohongo, Moroyama-cho, Saitama-ken, 
350-04 Japan. 
Abbreviations: 
ALM: acral lentiginous melanoma 
BCC: basal cell carcinoma 
MM: malignant melanoma 
NCC: National Cancer Center 
PEP: peplomycin 
PPSM: Palmo-plantar-subungual melanoma 
SCC: squamous cell carcinoma 
in the late period, while an even distribution between 40 and 
60 was found in the early period. The frequency of preceding 
diseases in squamous cell carcinoma was 8 times for actinic 
keratosis, 0.6 times for scars and 1.1 times for radiodermatitis. 
Absences of preceding diseases for the different malignancies 
in the early and later periods were 28% vs 43% of squamous 
cell carcinoma, 76% vs 86% of basal cell carcinoma, and 93% 
vs 97% of malignant melanoma. The number of squamous 
cell carcinoma and malignant melanoma on the head and 
neck increased 1.2 times and 4.5 times, respectively. The 
frequency in each disease was 46.0% for squamous cell carci­
noma and 11.1 % for malignant melanoma. Palmo-plantar­
subungual melanoma (PPSM) was seen in 40.7% and 34.5%. 
] Invest Dermatol 92:204S -209S, 1989 
MATERIALS AND METHODS 
Clinical and histologic records of patients with squamous cell carci­
noma, basal cell carcinoma, and malignant melanoma treated be­
tween 1962 and 1985 were reviewed. The patients in the early 
period (1962 -1972) were treated at Tokyo University and the Na­
tional Cancer Center. This survey compares these two periods con­
cerning the incidence, age, and sex distribution, preceding diseases, 
anatomical site of the lesion, and prognosis. Some analysis of the 
method of treatment was also performed. 
RESULTS 
Incidence of Squamous Cell Carcinoma, Basal Cell Carci­
noma, and Malignant Melanoma: Early Versus Late Period 
During the early period, squamous cell carcinoma was most fre­
quent (279 cases) followed by basal cell carcinoma (169 cases), and 
malignant melanoma (91 cases). In the late period, however, the 
number of cases was 203 for basal cell carcinoma, 248 for squamous 
cell carcinoma, and 307 in malignant melanoma, which indicated 
that both basal cell carcinoma and malignant melanoma had in­
creased 1.8 and 3.4 times, respectively. Squamous cell carcinoma 
decreased by 10% (Fig 1, Table I). 
Sex Distribution of Squamous Cell Carcinoma, Basal Cell 
Carcinoma, and Malignant Melanoma: Early Versus Late 
Period The male/female ratio of malignant skin tumor patients 
was 1.6 for basal cell carcinoma, 2 for squamous cell carcinoma, and 
1.7 for malignant melanoma in the early period. This changed to 
1.1, 1.7, and 1.2, respectively, in the late period. The sex ratio 
decreased toward unity in all 3 malignant skin tumors, but was still 
highest for squamous cell carcinoma (Table I). 
Age Distribution of Squamous Cell Carcinoma, Basal Cell 
Carcinoma, and Malignant Melanoma: Early Versus Late 
Period The age distribution of squamous cell carcinoma and basal 
cell carcinoma showed a sudden increase after ages 30 and 40, re-
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Figure 1. The number and incidence of skin malignant tumors in our hospitals between 1962 and 1985. 
spectively, in both the early and late periods. The peaks were during 
the fifties and sixties in the early period, and in the sixties during the 
late period. 
Malignant melanoma showed a relatively even distribution be­
tween 40 and 60 years of age in the early period. In the late period, 
however, there was a sudden increase after 20 years of age, with the 
peaks in the fifties (Figs 2 and 3). 
Antecedent Diseases in Squamous Cell Carcinoma: Early 
Versus Late Period Burn scars, traumatic scars, and chronic ra­
diodermatitis were the most common antecedent diseases: 35.5% 
and 27.7% in the early and late period, respectively. Squamous cell 
carcinoma arising in actinic keratosis increased from 3 cases in the 
early period to 20 cases in the late period (Table II). 
The number of patients with Bowen's disease (in situ squamous 
cell carcinoma) was nine in the early period and 10 in the late 
period. Almost all of them were on non-sun exposed sites in the 
early period, while about half of them were on sun-exposed sites in 
the late period. 
The number of patients with xeroderma pigmentosum was two 
in the early period and seven in the late period. 
Squamous cell carcinoma developing on organoid nevus was rare 
[4]: only one case in the early and late period. This is a sharp contrast 
to the case of basal cell carcinoma. 
As for other preceding diseases in squamous cell carcinoma, lupus 
erythematosus and porokeratosis [5] were seen in one and two cases, 
respectively. Antecedent diseases were undetermined in 28.3% and 
43.5% of squamous cell carcinoma in the early and later period, 
respectively. 
Table I. Number and Incidence of Malignant Skin Tumors in 
Our Hospitals 
1962-1972 1973-1985 
Male Female Total Male Female Total 
Bee 104 65 169 157 145 302 
see 186 93 279 155 93 248 
MM 57 34 91 167 140 307 
Tokyo Univ & Nee' Saitama Medical School & 
Nee 
, NCC: National Cancer Center 
Antecedent Diseases in Basal Cell Carcinoma: Early Versus 
Late Period About 80% of basal cell carcinoma was considered to 
have no apparent preceding diseases when the number of "pig­
mented mole" and "warts" was excluded, because of uncertain sig­
nificance (Table III). 
The number of basal cell carcinoma arising in xeroderma pig­
mentosus (XP) was 13 in the early period and six in the late period. 
Most xeroderma pigmentosum patients had multiple lesions on the 
exposed site, especially on the head and neck starting under 10 years 
of age. 
Basal cell carcinoma arising in organoid nevus was seen in five 
and seven cases, respectively, in the early and late period. Most 
patients had multiple tumors. Excepting one ten-year-old boy, all 
other cases were in their thirties. 
Basal cell carcinoma arising in radiodermatitis was seen in 11  
cases in the early period and seven in the late period. In  most patients 
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Figure 2. Age distribution of malignant melanoma and non-melanoma 
patients (1962-1972). 
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Figure 3. Age distribution of malignant melanoma and non-melanoma patients (1973-1985). 
tumors were multiple pigmented lesions caused by superficial or 
deep x-ray irradiation. 
There were seven cases of basal cell carcinoma patients with 
burned or traumatic scars in the early period and 13 in the late 
period. Most of them were seen on the head and neck of elderly 
persons. 
Gorlin-Goltz's syndrome affected four basal cell carcinoma pa­
tients: one in the early period and three in the late period. Two types 
were seen clinically: numerous milium-sized basal cell carcinoma 
diffusely distributed on the face and trunk, and multiple pigmented 
basal cell carcinoma of so-called "mole" -like lesions, larger than a 
fingertip in size, with the same distribution [6]. Each patient showed 
jaw cysts, various skeletal anomalies, and several palmo-plantar pits. 
One ll-year-old girl was operated on for medulloblastoma at two 
years of age. 
Preceding Disease in Malignant Melanoma: Early Versus 
Late Period No preceding disease was seen in 65.9% in the early 
period and 63.5% in the late period. "Pigmented moles" were seen 
in 27.5% of cases of malignant melanoma in the early period and 
Table II. Preceding Diseases in Squamous Cell Carcinoma 
1962-1972 1973-1985 
Burn scar 45 (16.1%) 33 (13.3%) 
Traumatic scar 29 (10.4%) 11 (4.4%) 
Scar 6 ( 2.2%) 2 ( 0.8%) 
Chronic Radiodermatitis 25 ( 9.0%) 24 ( 9.7%) 
Wart-like lesion 13 ( 4.7%) 7 ( 2.8%) 
Actinic Keratosis 3 ( 1.1%} 20 ( 8.1%) 
Xeroderma Pigmentosum 2 ( 0.7%) 7 ( 2.8%) 
Bowen's Disease 9 ( 3.2%) 10 ( 4.0%) 
Leukoplakia 6 ( 2.2%) 5 ( 2.0%) 
Organoid Epidermal Nevus 1 ( 0.4%) 1 ( 0.4%) 
Discoid Lupus Erythematous 1 ( 0.4%) 0 
Epidermodysplasia Verruciformis 1 ( 0.4%) 0 
Porokeratosis 0 2 ( 0.8%) 
Lupus Vulgaris 3 (  1.1%} 0 
Decubitus 1 ( 0.4%) 3 ( 1.2%) 
Fistula 4 ( 1.4%) 1 ( 0.4%) 
Phimosis 29 (10.4%) 0 
Miscellaneous 23 ( 8.2%) 14 ( 5.6%) 
None 79 (28.3%) 108 (43.5%) 
Total 279 248 
33.6% in the late period, but it was very difficult to tell whether 
they were in the early stage of malignant melanoma or preceding 
nevocytic nevi (Table IV). 
Malignant melanoma arising in xeroderma pigmentosum was 
seen in one case in both the early and late period. Both patients were 
middle-aged [7]. 
Giant pigmented nevi preceded in one case in both the early and 
late periods [8]. Both were under ten years of age. Congenital malig­
nant melanoma on pigmented nevi of medium size was seen in one 
case in the early period and two in the late period [9] (ages I, 10, and 
50). 
Malignant blue nevus, i.e., malignant melanoma arising on blue 
nevus [10], was seen in one case in the early period and two in the 
late period. All died of widespread metastasis with primary lesions 
on the head and neck. 
Malignant melanoma was seen on the lower leg in a female al­
bino, aged 27, in the late second period [11]. 
Anatomical Site of Squamous Cell Carcinoma: Early Versus 
Late Period Thirty-four percent of squamous cell carcinoma in 
the early period and 46% in the late period occurred on the head and 
neck. Next most common were the lower extremities/feet: 28.6% 
and 26.2%, respectively, in the early and late period. The incidence 
of squamous cell carcinoma occurring on the face increased from 
19.7% to 33.5% from one period to the next (Table V), while it 
decreased from 15.8% to 3.6% on the genital regions. 
Table III. Preceding Diseases in Basal Cell Carcinoma 
Pigmented tumor 
Xeroderma Pigmentosum 
Chronic Radiodermatitis 
Organoid Epidermal Nevus 
"Wart" 
Burn scar 
Traumatic scar 
Epidermodysplasia Verruciformis 
Gorlin-Goltz's Syndrome 
None 
Total 
1962-1972 
46 (27.2%) 
13 ( 7.7%) 
11 ( 6.5%) 
5 ( 3.0%) 
12 ( 7.1%) 
2 ( 1.2%) 
7 ( 4.1%) 
1 ( 0.6%) 
1 ( 0.6%) 
71 (42.0%) 
169 
1973-1985 
149 (49.3%) 
6 ( 2.0%) 
7 ( 2.3%) 
13 ( 4.3%) 
8 ( 2.6%) 
5 ( 1.7%) 
8 ( 2.6%) 
o 
3 ( 1.0%) 
103 (34.1%) 
302 
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Table IV. Preceding Diseases of Malignant Melanoma 
"Pigmented" tumor 
Xeroderma Pigmentosum 
Hurn Scar 
Werner's Syndrome 
Giant pigmented nevi 
Medium-sized pigmented nevi 
Blue nevus' 
Albino 
None 
Total 
1962-1972 
25 (27.5%) 
1 ( 1.1%) 
1 ( 1.1%) 
1 ( 1.1%) 
1 ( 1.1%) 
1 ( 1.1%) 
1 ( 1.1%) 
o 
60 (65.9%) 
91 
• Malignant melanoma occurring from dermal melanocytes. 
1973-1985 
103 (33.6%) 
1 ( 0.7%) 
1 ( 0.7%) 
o 
1 ( 0.7%) 
2 ( 0.7%) 
3 ( 1.0%) 
1 ( 0.3%) 
195 (63.5%) 
307 
Anatomical Site of Basal Cell Carcinoma: Early Versus Late 
Period Most of the basal cell carcinomas were seen on the head 
and neck region (83.5% and 72.1 %, respectively, in the early and 
late periods). The incidence of basal cell carcinoma on the trunk was 
8.3% and 12.9%, respectively, in the early and late periods, fol­
lowed by 4.2% to 5.3% on the lower extremity and 1.2% to 3.9% on 
the upper extremity (Table VI). 
Multiple basal cell carcinoma were seen in 6.5% and 7.0% of 
patients, respectively. One male patient, aged 38, developed a basal 
cell carcinoma on the sole [12). 
Anatomical Site of Malignant Melanoma: Early Versus Late 
Period Malignant melanoma on the feet was seen in 37.4% and 
34.2%, respectively, in the early and late periods. Acral lentiginous 
melanoma or palmo-plantar-subungual melanoma was seen in 
40.7% and 34.5% each: 2.2% to 2.3% for the palm, 31.9% to 27.7% 
for the sole and 6.6% to 4.5% for the subungual region (Table VII). 
The incidence of malignant melanoma on the head and neck, and 
trunk and hand increased from 7.7% to 11.1 %, 8.8% to 14.6%, and 
7.7% to 12.0%, respectively. The number of patients with malig­
nant melanoma on the head and neck increased 4.5 times in the late 
period. 
Prognosis and Treatment of Squamous Cell Carcinoma: 
Early Versus Late Period Survival rate of squamous cell carci­
noma was calculated according to the new TNM classification 
(UICC, 1987) comparing the early and late periods. The five-year 
survival rate was improved significantly in stage IV and slightly in 
stage III. In stages I and II, five-year survival was equally high in 
both periods. 
Almost all cases of squamous cell carcinoma were treated surgi­
cally in both the early and late period. Multidisciplinary treatment 
was also done in the late period [13,14). Some of the "inoperative" 
cases were also operated on after arterial infusion of peplomycin 
and/or combined therapy with peplomycin and electron beam. 
In cases of squamous cell carcinoma arising in an actinic keratosis, 
multiple precancerous lesions are apt to concentrate on the skin of 
Table V. Anatomical Site of Squamous Cell Carcinoma 
Head 
Face 
Lip 
Neck 
Upper extremity 
Hand & finger 
Trunk 
Inguinal region 
Hip 
Lower extremity 
Foot & toe 
Genital region 
Total 
1962-1972 
31 (11.1%) 
39 (14.0%) 
16 ( 5.7%) 
8 ( 2.9%) 
9 ( 3.2%) 
25 ( 9.0%) 
11 ( 6.5%) 
3 ( 1.1%) 
8 ( 2.9%) 
39 (14.0%) 
39 (14.6%) 
44 (15.8%) 
279 
1973 -1985 
26 (10.5%) 
61 (24.6%) 
22 ( 8.9%) 
5 ( 2.0%) 
9 ( 3.2%) 
29 (11.7%) 
12 ( 4.8%) 
3 ( 1.2%) 
8 ( 3.2%) 
34 (13.7%) 
31 (12.5%) 
9 ( 3.6%) 
248 
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Table VI. Anatomical Site of Basal Cell Carcinoma 
Head 
Forehead 
Temple 
Eyelid 
Nose 
Nasolabial fold 
Cheek 
Lip 
Auricle 
Neck 
Shoulder 
Axilla 
Upper arm 
Forehead 
Dorsum of hand 
Finger 
Chest 
Abdomen 
Inguinal 
Genital 
Back 
Lumbar 
Thigh 
Lower leg 
Dorsum of foot 
Sole 
Multiple 
Unknown 
Total 
1962-1972 
12 ( 7.1%) 
9 ( 5.3%) 
5 ( 3.0%) 
12 ( 7.1%) 
51 (30.2%) 
4 ( 2.4%) 
16 ( 9.5%) 
10 ( 5.9%) 
4 ( 2.4%) 
5 ( 3.0%) 
1 ( 0.6%) 
2 ( 1.2%) 
o 
2 ( 1.2%) 
1 ( 0.6%) 
1 ( 0.6%) 
4 ( 2.4%) 
1 ( 0.6%) 
4 ( 2.4%) 
4 ( 2.4%) 
o 
1 ( 0.6%) 
4 ( 2.4%) 
3 ( 1.8%) 
1 ( 0.6%) 
o 
11 ( 6.5%) 
1 ( 0.6%) 
169 
1973 -1985 
23 ( 7.6%) 
13 ( 4.3%) 
2 ( 0.7%) 
17( 5.6%) 
59 (19.5%) 
8 ( 2.6%) 
52 (17.2%) 
13 ( 4.3%) 
5 ( 1.7%) 
3 ( 1.0%) 
3 ( 1.0%) 
4 ( 1.3%) 
5 ( 1.7%) 
6 ( 2.0%) 
2 ( 0.7%) 
1 ( 0.3%) 
10 ( 3.3%) 
7 ( 2.3%) 
3 ( 1.0%) 
3 ( 1.0%) 
13 ( 4.3%) 
3 ( 1.0%) 
5 ( 1.7%) 
11 ( 3.6%) 
o 
1 ( 0.3%) 
21 ( 7.0%) 
8 ( 2.6%) 
302 
Table VII. Anatomical Site of Malignant Melanoma 
1962-1972 1973 -1985 
Head 2 ( 2.2%) 10 ( 3.3%) 
Face 5 ( 5.5%) 16 ( 5.2%) 
Neck 0 8 ( 2.6%) 
Shoulder 0 11( 3.6%) 
Axilla 3 ( 3.3%) 0 
Upper arm 1 ( 1.1%) 10 ( 3.3%) 
Forearm 6 ( 6.6%) 7 ( 2.3%) 
Dorsum of hand 0 1 ( 0.3%) 
Palm 2 ( 2.2%) 7 ( 2.3%) 
Finger 2 ( 2.2%) 16 ( 5.2%) 
Subungual 3 ( 3.3%) 13 ( 4.2%) 
Chest 3 ( 3.3%) 13 ( 4.2%) 
Abdomen 0 2 ( 0.7%) 
Inguinal 1 ( 1.1%) 1 ( 0.3%) 
Genital 1 ( 1.1%) 8 ( 2.6%) 
Back 2 ( 2.2%) 13 ( 4.2%) 
Lumbar 0 4 ( 1.3%) 
Buttock 1 ( 1.1%) 4 ( 1.3%) 
Thigh 1 ( 1.1%) 15 ( 4.9%) 
Lower leg 14 (15.4%) 27 ( 8.8%) 
Dorsum of foot 0 7 ( 2.3%) 
Sole 29 (31.9%) 85 (27.7%) 
Toe 2 ( 2.2%) 12 ( 3.9%) 
Subungual 3 ( 3.3%) 1 ( 0.3%) 
Multiple 0 1 ( 0.3%) 
Miscellaneous 10 (11.0%) 12 ( 3.9%) 
Leptomeninges 1 ( 1.1%) 0 
Palp. conjunctiva 3 ( 3.3%) 1 ( 0.3%) 
Bulb. conjunctiva 0 1 ( 0.3%) 
Nasal caviry 3 ( 3.3%) 1 ( 0.3%) 
Lip 0 5 ( 1.6%) 
Oral cavity 1 ( 1.1%) 3 ( 1.0%) 
Perianal 2 ( 2.2%) 0 
Vagina 0 1 ( 0.3%) 
Unknown 0 3 ( 1.1%) 
Total 101 303 
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Survival of squamous cell carcinoma (1962� 1972) 
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Figure 4. Survival of squamous cell carcinoma patients (1962-1972). 
the scalp or forehead. We often performed a wide excision, includ­
ing sun-damaged skin, followed by a skin graft from an unexposed 
donor site [15]. The same approach was employed in cases of squa­
mous cell carcinoma from radiodermatitis. This procedure can re­
move squamous cell carcinoma together with the surrounding pre­
malignant lesions. In addition, aesthetic results were excellent in 
our patients. 
Prognosis and Treatment of Basal Cell Carcinoma: Early 
Versus Late Period Five-year survival rates in basal cell carci­
noma were 100% in both the early and late periods. Most cases were 
treated surgically, but about 10% of them were treated by radiation 
at the National Cancer Center hospital in the early period. No cases 
were treated by topical or systemic chemotherapy. 
Lymph-node metastasis was seen in a female patient aged 58 in 
the late period. Her primary lesion was a deeply invasive basal cell 
carcinoma (T4NoMo) on the right, lower eyelid, which recurred 
nine years after the first operation. Radical operations, including 
submandibular lymph node dissection, were successful, and she is 
still free of recurrence 4 years later [16]. 
Multiple basal cell carcinoma arising in xeroderma pigmentosum 
or chronic radiodermatitis was treated by wide excision, including 
potential premalignant lesions, followed by a skin graft. 
Prognosis and Treatment of Malignant Melanoma: Early 
Versus Later Period The 5-year survival rate in malignant mela­
noma was improved in all stages, especially from in stage I (75% to 
Survival of squamous cell carcinoma (1973�1985) 
stage I n=64 
stage" n=103 
stage III n=63 
stagel\· n = 18 
2 5 year 
Figure 5. Survival of squamous cell carcinoma patients (1973 -1985). 
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Figure 6. Survival of malignant melanoma patients (1962 -1972). 
100%) and stage III (12.6% to 48%). Improvement in stage IV was 
also remarkable (Figs 6 and 7). 
The most important difference in the treatment of malignant 
melanoma in the late period was application of chemotherapy and 
immunotherapy [17 -20]. In cases of stage IV, metastatic tumors on 
the brain, skin, and liver were resected energetically when possible 
and treated with chemoimmunotherapy, especially when they were 
solitary and localized. This might explain increased survival in the 
late period. 
The 5-year survival rate was increased even in the case of acral 
lentiginous melanoma, which had the poorest prognosis in the early 
period. This might result from prophylactic dissection of regional 
nodes on all cases in stage II and III [21], as well as earlier diagnosis, 
especially of in situ lesions. The five-year survival rate was 69% for 
the lymph-node dissection group versus 37% for the non-dissection 
group. When the tumor was thicker than 3.0 mm (Breslow's thick­
ness), continuous subtotal integumentectomy was performed in an 
attempt to decrease the in-transit metastases [22]. 
DISCUSSION 
The present survey differs from previous surveys in three ways. 
First, the surveyed period was the longest (22 years); those of the 
previous reports were all under ten years. Second, materials came 
from two representative cancer clinics in Japan; previous reports 
were derived from multiple hospitals (120 hospitals in Segi's report 
and 41 in Miyagi's report). Third, the survey was done comparing 
two different time periods (1962-1972) and (1973-1985). 
Survival of maligmant melanoma (1973�1985) 
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Figure 7. Survival of malignant melanoma patients (1973 -1985). 
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The mean number of yearly onset of malignant melanoma pa­
tients increased 2.8 times, and that of basal cell carcinoma increased 
1.5 times during the 12 years of the late period. The increase might 
have come from an increase in environmental carcinogenic factors 
in the elderly population and in the number of patients who were 
anxious about "black cancer" from increased awareness through the 
media. The number of squamous cell carcinoma patients decreased 
0.7 times. 
A noticeable change was seen in the age distribution of malignant 
melanoma patients in the late period (a sudden increase after 20 
years of age with peaks in fifties). This might be partly due to an 
increase in early recognition. The age distribution in the early pe­
riod was comparable to other previous reports [23,24]. 
The most common antecedent diseases for squamous cell carci­
noma in Japan are burn scars, traumatic scars, and chronic radioder­
matitis, which constituted 35.5% of squamous cell carcinoma in the 
early period and 27.4% in the late period. The number of patients 
with burn or traumatic scars decreased by 46% in the late period, 
while that with radiodermatitis was constant. 
The number of squamous cell carcinoma cases arising in actinic 
keratosis increased about eightfold in the late period partly because 
of an increased elderly population. In Bowen's disease the lesions on 
exposed sites increased twice in the late period, suggesting a contri­
bution of some different factors in this disease [25]. 
In case of basal cell carcinoma, 34.3% and 51. 9% in the early and 
late period, respectively, were derived from "pigmented mole" 
and/or "warts." We excluded them from the preceeding disease 
because there was no way to distinguish them from the early stage of 
basal cell carcinoma. Therefore, 76% to 86% of basal cell carcinoma 
cases were considered to have no apparent preceding diseases prior 
to the development of the tumor. 
The number of basal cell carcinoma cases from organoid nevus 
increased 2.6 times in the late period, which might be due to a 
popularized knowledge of "potential premalignant lesions." 
In more than 93% of cases of malignant melanoma, the preceding 
disease was not determined, as we excluded the "pigmented moles" 
because of their obscure nature (they might be an early lesion of 
malignant melanoma). Although infrequent, medium-sized pig­
mented nevi must not be neglected as a source of malignant mela­
noma. In our series, the number of malignant melanoma arising in 
medium-sized pigmented nevi was three and two in patients with 
giant pigmented nevi. 
As a whole, comparing the early and late periods of study, abour 
28% vs 43% of squamous cell carcinoma, 76% vs 96% of basal cell 
carcinoma, and 93% vs 97% of malignant melanoma had no appar­
ent predisposing conditions prior to the development of tumors. 
Concerning the anatomical site of squamous cell carcinoma, most 
lesions were concentrated on the head and neck and lower extremi­
ties, including feet (e.g., 62.6% in the early period and 72.2% in the 
late
. 
period). We can relate this fact to the predilection of scars and 
�adlOdermatitis, which are the most common predisposing diseases 
�n Japan. The incidence of squamous cell carcinoma on the face 
Increased 1.7-fold in the late period, which may be attributable to a 
recent increase in actinic keratosis. 
The anatomical predilection of basal cell carcinoma for the face 
was 65.8% and 55.9% in the early and late periods, respectively. 
The anatomical predilections of malignant melanoma were sole, 
palm, and subungual regions, acral lentiginous melanoma, the fre­
quency of which was similar in both the early and late period. The 
�umber of malignant melanoma in the head and neck increased 4.5 
t�mes in the late period, suggesting some relationship in UV radia­
tion on the development of malignant melanoma. 
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